The cost-effectiveness of an HCV outreach intervention for at-risk populations in London, UK.

ABSTRACT:

Background

HCV disproportionately affects marginalized communities such as homeless populations and people who inject drugs (PWID), posing a challenge to traditional health services. The HepFriend initiative in London is a model of care utilizing HCV outreach screening and peer support to link vulnerable individuals to HCV treatment in secondary care.

Objectives

To assess the cost-effectiveness of the HepFriend initiative from a healthcare provider perspective, compared with standard-of-care pathways (consisting of testing in primary care and other static locations, including drug treatment centres, and linkage to secondary care).

Methods

Cost-effectiveness analysis using a dynamic HCV transmission and disease progression model among PWID and those who have ceased inj

SUBMITTER: Ward Z 

PROVIDER: S-EPMC6883400 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature